By Institution. Institution shall indemnify, defend, and hold harmless Sponsor, their affiliated entities, and their respective agents, contractors, and personnel (collectively, the “Sponsor Indemnitees”) from and against any and all actual Losses resulting from or arising out of any third party claims, actions or proceedings relating to any Institution Indemnitee’s (a) wrongful or negligent actions or omissions, or willful misconduct or other misuse of the Study Drug; (b) failure to follow any applicable laws, regulations and guidelines, or to conform to reasonable and prudent clinical practices, including GCPs as applicable to drug studies; (c) failure to follow the Protocol or other information provided by or on behalf of Sponsor to the Institution Indemnitees; and (d) prior treatment for the underlying or preexisting condition.
Appears in 1 contract
Sources: Clinical Trial Research Agreement
By Institution. Institution shall indemnify, defend, and hold harmless Sponsor, their affiliated entities, and their respective agents, contractors, and personnel (collectively, the “Sponsor Indemnitees”) from and against any and all actual and alleged Losses resulting from or arising out of any third party claims, actions or proceedings relating to any Institution Indemnitee’s (a) wrongful or negligent actions or omissions, or willful misconduct or other misuse of the Study Drug; (b) failure to follow any applicable laws, laws regulations and guidelines, or to conform to reasonable and prudent clinical practices, including GCPs as applicable to drug studies; (c) failure to follow the Protocol or other information provided by or on behalf of Sponsor to the Institution Indemnitees; and (d) prior treatment for the underlying or preexisting condition.
Appears in 1 contract
Sources: Clinical Trial Research Agreement